Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes

Abstract

Type 2 diabetes is a polygenic and genetically heterogenous disease1. The age of onset of the disease is usually late and environmental factors may be required to induce the complete diabetic phenotype. Susceptibility genes for diabetes have not yet been identified. Islet-brain-1 (IB1, encoded by MAPK8IP1), a novel DNA-binding transactivator of the glucose transporter GLUT2 (encoded by SLC2A2), is the homologue of the c-Jun amino-terminal kinase-interacting protein-1 (JIP-1; refs 2,3,4,5). We evaluated the role of IB1 in β-cells by expression of a MAPK8IP1 antisense RNA in a stable insulinoma β-cell line. A 38% decrease in IB1 protein content resulted in a 49% and a 41% reduction in SLC2A2 and INS (encoding insulin) mRNA expression, respectively. In addition, we detected MAPK8IP1 transcripts and IB1 protein in human pancreatic islets. These data establish MAPK8IP1 as a candidate gene for human diabetes. Sibpair analyses performed on 149 multiplex French families with type 2 diabetes excluded MAPK8IP1 as a major diabetogenic locus. We did, however, identify in one family a missense mutation located in the coding region of MAPK8IP1 (S59N) that segregated with diabetes. In vitro , this mutation was associated with an inability of IB1 to prevent apoptosis induced by MAPK/ERK kinase kinase 1 (MEKK1) and a reduced ability to counteract the inhibitory action of the activated c-JUN amino-terminal kinase (JNK) pathway on INS transcriptional activity. Identification of this novel non-maturity onset diabetes of the young (MODY) form of diabetes demonstrates that IB1 is a key regulator of β-cell function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Effect of MAPK8IP1 antisense RNA in INS1 cells.
Figure 2: Segregation analysis of MAPK8IP1 S59N and IPF1 Q59L mutations in pedigree F514.
Figure 3: The MAPK8IP1 S59N mutation is a weaker inhibitor of the JNK-activated repression of INS and is associated with an accelerated pro-apoptotic program.

Similar content being viewed by others

References

  1. Kahn, B.B. & Rossetti, L. Type 2 diabetes—who is conducting the orchestra? Nature Genet. 20, 223– 225(1998).

    Article  CAS  Google Scholar 

  2. Bonny, C., Nicod, P. & Waeber, G. IB1, a JIP-1 related nuclear protein present in insulin-secreting cells. J. Biol. Chem. 273, 1843– 1846 (1998).

    Article  CAS  Google Scholar 

  3. Dickens, M. et al. A cytoplasmic inhibitor of the JNK signal transduction pathway . Science 277, 693–696 (1997).

    Article  CAS  Google Scholar 

  4. Whitmarsh, A.J., Cavanagh, J., Tournier, C., Yasuda, J. & Davis, R.J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281, 1671–1674 (1998).

    Article  CAS  Google Scholar 

  5. Mooser, V. et al. Genomic organization, fine mapping and expression of the human islet-brain 1(IB1)/c-Jun-amino-terminal kinase interacting protein-1 (JIP-1) gene. Genomics 55, 202– 208 (1999).

    Article  CAS  Google Scholar 

  6. Thorens, B., Weir, G.C., Leahy, J.L., Lodish, H.F. & Bonner-Weir, S. Reduced expression of the liver/β-cell glucose transporter isoform in glucose-insensitive pancreatic β cells of diabetic rats. Proc. Natl Acad. Sci. USA 87, 6492 –6496 (1990).

    Article  CAS  Google Scholar 

  7. Thorens, B., Wu, Y.J., Leahy, J.L. & Weir, G.C. The loss of GLUT2 expression by glucose-unresponsive B cells of db/db mice is reversible and is induced by the diabetic environment. J. Clin. Invest. 90, 77–85 (1992).

    Article  CAS  Google Scholar 

  8. Guillam, M.-T. et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking GLUT-2. Nature Genet. 17, 327–330 (1997).

    Article  CAS  Google Scholar 

  9. Waeber, G., Thompson, N., Haefliger, J.-A. & Nicod, P. Characterization of the murine high Km glucose transporter GLUT2 gene and its transcriptional regulation by glucose in a differentiated insulin-secreting cell line. J. Biol. Chem. 269, 26912– 26919 (1994).

    CAS  PubMed  Google Scholar 

  10. Bonny, C., Thompson, N., Nicod, P. & Waeber, G. Pancreatic-specific expression of the glucose transporter type 2 gene: identification of cis -elements and islet-specific trans-acting factors. Mol. Endocrinol. 9, 1413–1426 (1995).

    CAS  PubMed  Google Scholar 

  11. Waeber, G., Thompson, N., Nicod, P. & Bonny, C. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol. Endocrinol. 10, 1327–1334 (1996).

    CAS  PubMed  Google Scholar 

  12. Waeber, G. et al. Insulin secretion is regulated by the glucose-dependent production of islet β cell macrophage migration inhibitory factor. Proc. Natl Acad. Sci. USA 94, 4782–4787 (1997).

    Article  CAS  Google Scholar 

  13. Zouali, H. et al. Linkage analysis and molecular scanning of glucokinase gene in NIDDM families. Diabetes 42, 1238– 1245 (1993).

    Article  CAS  Google Scholar 

  14. Hani, E.H. et al. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J. Clin. Invest. 104, R41–R48 (1999).

    Article  CAS  Google Scholar 

  15. Inagaki, N. et al. C-jun represses the human insulin promoter activity that depends on multiple cAMP response elements. Proc. Natl Acad. Sci. USA 89, 1045–1049 (1992).

    Article  CAS  Google Scholar 

  16. Henderson, E. & Stein, R. c-jun inhibits transcriptional activation by insulin enhancer, and the insulin control element is the target of control . Mol. Cell. Biol. 14, 655– 662 (1994).

    Article  CAS  Google Scholar 

  17. Robinson, G.L., Henderson, E., Massari, M.E., Murre, C. & Stein, R. c-Jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products . Mol. Cell. Biol. 15, 1398– 1404 (1995).

    Article  CAS  Google Scholar 

  18. Widman, C., Gerwins, P., Lassignal Johnson, N., Jarpe, M.B. & Johnson, G.L. MEKK1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18, 2416–2429 ( 1998).

    Article  Google Scholar 

  19. Ip, Y.T. & Davis, R.J. Signal transduction by the c-Jun N-terminal kinase (JNK). From inflammation to development. Curr. Opin. Cell Biol. 10, 205–219 (1998).

    Article  CAS  Google Scholar 

  20. Widmann, C., Johnson, N.L., Garner, A.M., Smith, R.J. & Johnson, G.L. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1. Oncogene 15, 2439–2447 ( 1997).

    Article  CAS  Google Scholar 

  21. Ohlsson, H., Karlsson, K. & Edlund, T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 12, 4251– 4259 (1993).

    Article  CAS  Google Scholar 

  22. Pellet, J.-B. et al. Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain. Eur. J. Neurosci. 12, 1–12 (2000 ).

    Article  Google Scholar 

  23. Gremlich, S., Bonny, C., Waeber, G. & Thorens, B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin and somatostatin levels. J. Biol. Chem. 272, 30261–30269 (1997).

    Article  CAS  Google Scholar 

  24. Jonas, J.-C. et al. Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes. J. Biol. Chem. 274, 1412–1421 ( 1999).

    Article  Google Scholar 

  25. Wang, H.P. & Iynedjian, P. Modulation of glucose responsiveness of insulinoma β-cells by graded overexpression of glucokinase. Proc. Natl Acad. Sci. USA 94, 4372– 4377 (1997).

    Article  CAS  Google Scholar 

  26. Vionnet, N. et al. Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs. Diabetes 46, 1062 –1068 (1997).

    Article  CAS  Google Scholar 

  27. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20, 1183–1197 (1997).

  28. Haseman, J.K. & Elston, R.C. The investigation of linkage between a quantitative trait and a marker locus. Behav. Genet. 2, 3–19 (1972).

    Article  CAS  Google Scholar 

  29. O'Connel, J.R. & Weeks, D.E. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recording and fuzzy inheritance. Nature Genet. 11, 402 –408 (1995)

    Article  Google Scholar 

Download references

Acknowledgements

We thank J. Oberholzer for freshly isolated human pancreatic islets; P. Fontana for help in statistical analysis; and P. Gallina for collecting diabetic families and patient data. G.W., C.B. and V.M. are supported by the Swiss National Science Foundation (grants 32-48916.96, 32-94471.95 and 32-54119.98) and the Placide Nicod and Botnar Foundations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gérard Waeber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waeber, G., Delplanque, J., Bonny, C. et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 24, 291–295 (2000). https://doi.org/10.1038/73523

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/73523

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing